← Back to Dashboard

TORNTPHARM Torrent Pharmaceuticals Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare
₹ 4,410.40
-0.24%

Smart Money Verdict synthesis of derivatives, deals, and promoter files

No significant institutional activity detected
Derivative metrics and institutional flows are quiet. No recent bulk deals or insider disclosures have been reported.

Analysis what the data is telling us about TORNTPHARM

In the last completed session, Torrent Pharmaceuticals Ltd. closed -0.42% with futures open interest moving +0.2%. Positioning is neutral — neither side is decisively adding or unwinding right now. The stock's option PCR sits at 0.47, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹4,450 sits 0.9% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Torrent Pharmaceuticals Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Torrent Pharmaceuticals Ltd. lacks a clear directional bias.

F&O Positioning EOD derivatives setup

Buildup Class
Neutral
bias: neutral
Futures OI
3,122,250
+4875 (+0.2%)
Option PCR (OI)
0.47
heavy call writing
Max Pain Strike
₹ 4,450
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 4,420.90
yesterday's EOD close
Index Contribution
not a Nifty 50 constituent
Traded Volume
389,687
live shares traded today
Upcoming Earnings
no report scheduled

Technical Snapshot from 400 sessions of price history

RSI (14)
52.2
neutral momentum
52-Week High
₹ 4,712.90
-6.4% from high
52-Week Low
₹ 3,108.80
+41.9% above low
200-DMA
₹ 3,953.92
+11.5% · above trend
50-DMA
₹ 4,283.40
+3.0% from 50-DMA
1-Year Return
+40.7%
1M +0.7%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
68.8
price / earnings
P/B
17.7
price / book
ROE
17.0%
return on equity
Market Cap
₹ 149,268 Cr
total market value
Dividend Yield
0.86%
trailing yield
EPS (TTM)
₹ 64.10
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-06-30 · spot 4,410 · EOD 2026-06-08

Option writers expect range between 4,400 and 4,700+6.6% upside, -0.2% downside.
upside-skewed
Call OI (writers) Strike Put OI (writers)
0
4100
15,125 +0k
0
4150
12,125 -4k
IV 25% Δ -0.14 θ -1.3 ν 2
2,625 +0k
IV 34% Δ 0.75 θ -3.2 ν 3
4200
31,125 -6k
IV 25% Δ -0.18 θ -1.5 ν 3
0
4250
10,125 +3k
IV 24% Δ -0.24 θ -1.6 ν 3
29,125 -2k
IV 27% Δ 0.68 θ -2.8 ν 4
4300
36,125 -6k
IV 24% Δ -0.30 θ -1.8 ν 4
19,250 -1k
IV 24% Δ 0.63 θ -2.7 ν 4
4350
24,375 -12k
IV 23% Δ -0.37 θ -1.9 ν 4
34,250 -2k
IV 26% Δ 0.55 θ -2.9 ν 4
4400 S
52,500 +2k
IV 23% Δ -0.44 θ -1.9 ν 4
42,000 +1k
IV 26% Δ 0.48 θ -2.9 ν 4
4450 MP
17,000 +4k
IV 23% Δ -0.53 θ -1.8 ν 4
73,375 +5k
IV 26% Δ 0.41 θ -2.8 ν 4
4500
45,750 +6k
IV 23% Δ -0.60 θ -1.7 ν 4
26,750 +14k
IV 26% Δ 0.34 θ -2.6 ν 4
4550
2,125
IV 43% Δ -0.58 θ -3.6 ν 4
76,000 +15k
IV 26% Δ 0.28 θ -2.3 ν 4
4600
26,375 -1k
IV 22% Δ -0.75 θ -1.1 ν 3
17,375 -8k
IV 26% Δ 0.23 θ -2.2 ν 3
4650
4,000
IV 30% Δ -0.74 θ -1.8 ν 4
111,250 -7k
IV 26% Δ 0.19 θ -1.9 ν 3
4700 R
9,000
IV 40% Δ -0.71 θ -2.8 ν 4

Chain Interpretation

Spot Underlying 4,410.40
Key Resistance (R) 4,700
Key Support (S) 4,400
Max Pain Strike (MP) 4,450
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for TORNTPHARM options · 2026-06-30 expiry

Underlying: TORNTPHARM · Spot: ₹ 4,410.40 · Expiry: 2026-06-30 · Lot: 125

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others